Molecules/PALIVIZUMAB

PALIVIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 1998

Mechanism of action: Fusion glycoprotein F0 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

MEDI-493PALIVIZUMABSYNAGISSYNAGIS ABBOSYNAGIS

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to PALIVIZUMAB

Loading drug network...